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Pulmonary Metastases from Cervical Adenocarcinoma
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Abstract: A 38-year-old woman with recurrent metastatic cervi-
cal adenocarcinoma developed innumerable bilateral solid and
cavitating pulmonary metastatic nodules. After chemotherapy
with paclitaxel and carboplatin, all these nodules regressed to air
filled cystic structures with imperceptible walls, pneumatoceles.
Immunocompromised patients require close monitoring for de-
velopment of these as they may be complicated by secondary
infection, pneumothorax formation or develop into a tension
pneumatocele.
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Untreated pulmonary metastases, including those fromcervical adenocarcinoma, commonly present as solid or
cavitating nodules on computed tomography (CT) examina-
tions of the chest.1–5 Partial regression following treatment is
described as lesion stability or reduction in number and/or
size of lesions. Complete regression requires entire disap-
pearance of the nodules or residual scar formation.1,2,4
This case highlights an unusual pattern of regression in
which innumerable bilateral solid and cavitating pulmonary
metastases from metastatic cervical adenocarcinoma all trans-
formed into pneumatoceles with imperceptible walls follow-
ing paclitaxel and carboplatin chemotherapy.
CASE REPORT
A 38-year-old woman presented with cervical adeno-
carcinoma diagnosed from a routine Papanicolau test. Exam-
ination under anesthesia revealed a 4 cm exophytic mobile
cervical mass staged FIGO 1B2. Magnetic resonance imaging
of the pelvis showed no tumor extension to the parametria,
urinary bladder or rectum, however, iliac lymph nodes
were regarded suspicious with subsequent Positron Emis-
sion Tomography scan demonstrating uptake in the tumor,
lower uterine segment, left iliac and para-aortic lymph
nodes (Figure 1).
Initial treatment consisted of chemo-radiotherapy in-
cluding weekly cisplatin, external beam radiation (45 Gy in
25 fractions over 5 weeks plus reduced volume boost of 50.4
Gy in 28 fractions over 5.5 weeks) to pelvic and para-aortic
lymph nodes and pelvic brachytherapy (5.4 Gy in 3 fractions
over 5 weeks). The cisplatin was ceased after 3 weeks due to
gastrointestinal toxicity and pancytopenia.
Restaging CT and Positron Emission Tomography per-
formed 4.5 months after the completion of the initial chemo-
radiotherapy revealed local pelvic recurrence and widespread
metastatic disease. A subsequent CT 3 months later demon-
strated innumerable bilateral solid and cavitating pulmonary
nodules, all measuring less than 1 cm diameter (Figures 2A,
B) and mediastinal and hilar lymphadenopathy (Figure 2C).
Palliative chemotherapy with weekly paclitaxel (80 mg/m2)
and carboplatin (area under curve  2) was commenced with
three cycles being completed before the patient developed
neutropenia and thrombocytopenia. Chemotherapy was
ceased for 4 weeks before weekly paclitaxel (80 mg/m2) was
reinstituted for 11 cycles. Ongoing bone marrow toxicity
required a reduced dose (60 mg/m2) for the last two cycles.
The palliative chemotherapy was ceased after 14 cycles as the
potential risks of ongoing bone marrow toxicity were deemed
to outweigh the potential benefits of further treatment.
Repeat CT performed at the time of paclitaxel recom-
mencement demonstrated complete transformation of all the
pulmonary nodules to pneumatoceles with imperceptible
walls (Figures 3A, B), in addition to global reduction in the
chest and abdomino-pelvic lymphadenopathy. A CT 3
months later, 15 months after commencement of the initial
chemo-radiotherapy, confirmed stability of the pneumatoce-
les and lymph nodes.
DISCUSSION
Pulmonary metastases commonly present as solid or
cavitating nodules, the latter being described in cases of
adenocarcinoma, squamous cell carcinoma, synovial sar-
coma, and transitional cell carcinoma.1,2,4–9
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Complete regression of solid pulmonary metastases
arising from cervical adenocarcinoma, squamous cell carci-
noma and endometrial adenocarcinoma after treatment with
systemic paclitaxel and carboplatin has been described.1,2,4,5
In these cases, the metastatic pulmonary nodules were either
replaced by scar tissue or disappeared completely leaving
normal lung on subsequent CT examinations.
Our report presents an unusual outcome in a patient
with recurrent metastatic cervical adenocarcinoma in which
FIGURE 1. Positron Emission Tomography (PET) image
demonstrating intense F-18 Fluorodeoxyglucose (FDG) up-
take by uterine cervix, lower uterine segment, left iliac
lymph nodes (arrow), and L2 retroperitoneal lymph nodes. FIGURE 2. Axial computed tomography (CT) chest (lung
window) demonstrating multiple bilateral solid and cavi-
tating pulmonary metastases (arrows) at (A) carinal and
(B) subcarinal levels. C, Restaging Positron Emission To-
mography (PET) image confirming metastatic activity with
intense F-18 Fluorodeoxyglucose (FDG) uptake in bilateral
iliac, left inguinal (arrowhead), left pelvic wall, para-aortic
and retro-crural regions as well as within the lungs and
Virchow node (arrow).
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innumerable solid and cavitating pulmonary metastases re-
gressed to stable pneumatoceles following palliative pacli-
taxel chemotherapy. To our knowledge, this outcome has not
been described in the literature.
Pneumatoceles are thin-walled air filled cysts which
arise within lung parenchyma and are classically associated
with infection, hydrocarbon ingestion, trauma or positive
pressure ventilation. Regardless of their etiology, pneu-
matoceles may be complicated by secondary infection,
pneumothorax and may develop into a tension pneumato-
cele.10 Patients in which pulmonary metastases regress to
pneumatoceles with chemotherapy treatment should be
closely monitored for development of these complications,
especially secondary infection, given the patients’ poten-
tial immunocompromise.
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FIGURE 3. Axial computed tomography (CT) chest (lung
window) showing regression of solid and cavitating pulmo-
nary metastases to pneumatoceles (arrows) at (A) carinal and
(B) subcarinal levels.
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